Differences In The Severity Of Diabetic Neuropathy Based On Electromyography In Type 2 Diabetes Mellitus Patients With And Without Comorbidities
DOI:
https://doi.org/10.36408/mhjcm.v12i3.1357Keywords:
Type 2 Diabetes Mellitus, Diabetic Neuropathy, Electromyography, Hypertension, HyperlipidemiAbstract
Introduction: Diabetic neuropathy is one of the most common complications of type 2 Diabetes Mellitus. Hyperglycemia causes axonal abnormalities and impaired schwan cell metabolism. Hypertension and hyperlipidemia associated with atherosclerosis, lipid metabolism and arterial compliance. This study aims to determine the difference in the severity of diabetic neuropathy based on electromyography between type 2 DM patients with and without comorbidities.
Methods: This study used a cross sectional design. A total of 78 diabetic neuropathy subjects from Outpatient Installation of Dr. Kariadi Hospital Semarang were divided into 3 groups, 26 subjects without comorbidities, 25 subjects with comorbid hypertension and 27 subjects with comorbid hypertension and hyperlipidemia. Inclusion criteria were aged 40-80 years, distal symmetrical polyneuropathy classification, without comorbid and with comorbid hypertension and hyperlipidemia. Exclusion criteria were patients with chemotherapy, HNP, CKD stage 5, incomplete medical records. Data were analyzed using Kruskal-Wallis comparative test.
Results: There is a difference in the severity of diabetic neuropathy based on EMG between type 2 DM patients without comorbidities and with comorbidities (p<0.01). No difference in the severity between patients with type 2 DM without comorbidities and with comorbid hypertension (p 0.058). There is a difference in the severity between patients with type 2 DM without comorbidities and with comorbid hypertension and hyperlipidemia (p<0.01).
Conclusion: There is a difference in the severity of diabetic neuropathy based on EMG between patients with type 2 DM without comorbidities, with comorbid hypertension and with comorbid hypertension and hyperlipidemia. The more comorbidities, the greater the severity of diabetic neuropathy.
Downloads
References
1. Yavuz DG. Chapter 1 - Classification, risk factors, and clinical presentation diabetic neuropathy. In: Tavakoli M, editor. Diabetic Neuropathy [Internet]. Elsevier; 2022. p. 1–9. Available from: https://www.sciencedirect.com/science/article/pii/B9780128206690000141
2. Ohiagu F, Chikezie P, Chikezie C. Pathophysiology of diabetes mellitus complications: Metabolic events and control. Biomedical Research and Therapy. 2021;8(3):4243–57. Available from: https://doi.org/10.15419/bmrat.v8i3.663
3. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. Available from: https://doi.org/10.3390/ijms21176275
4. Hansen C, Määttä L, Andersen S, Charles M. The epidemiology of diabetic neuropathy. In: Tesfaye S, Selvarajah D, editors. Diabetic Neuropathy. Humana Cham; 2023. p. 5–36. Available from: https://doi.org/10.1007/978-3-031-15613-7_2
5. Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Pathogenesis of distal symmetrical polyneuropathy in diabetes. Life (Basel). 2022;12(7):1074. Available from: https://doi.org/10.3390/life12071074
6. Pang L, Lian X, Liu H, Zhang Y, Li Q, Cai Y, et al. Understanding diabetic neuropathy: focus on oxidative stress. Oxid Med Cell Longev. 2020;2020:1–13. Available from: https://doi.org/10.1155/2020/9524635
7. Iqbal Z, Bashir B, Ferdousi M, Kalteniece A, Alam U, Malik RA, et al. Lipids and peripheral neuropathy. Lipidology. 2021;32(4):249–57. Available from: https://doi.org/10.1097/MOL.0000000000000770
8. Huang L, Zhang Y, Wang Y, Shen X, Yan S. Diabetic peripheral neuropathy is associated with higher systolic blood pressure in adults with type 2 diabetes with and without hypertension in the chinese han population. Can J Diabetes. 2020;44(7):615–23. Available from: https://doi.org/10.1016/j.jcjd.2019.11.005
9. Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of hypertension: the mosaic theory and beyond. Ciculation Research. 2021;128(7):847–63. Available from: https://doi.org/10.1161/circresaha.121.318082
10. Webb AJS, Werring DJ. New insights into cerebrovascular pathophysiology and hypertension. Stroke AHA. 2022;53(4):1054–64. Available from: https://doi.org/10.1161/STROKEAHA.121.035850
11. Lan YR, Chiu WC, Huang CC. HbA1C variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes. Front Neurosci. 2019;13:90. Available from: https://doi.org/10.3389/fnins.2019.00090
12. Diwan J, Patel K, Goswami D, Patel V. Sensory nerve conduction velocity study in diabetic patients. Natl J Physiol Pharm Pharmacol. 2021;11(3):315–9. Available from: http://dx.doi.org/10.5455/njppp.2021.11.01028202122012021
13. Lu Y, Xing P, Cai X, Luo D, Li R, Lloyd C, et al. Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: estimates of the INTERPRET-DD Study. Front Public Health. 2020;8:534372. Available from: https://doi.org/10.3389/fpubh.2020.534372
14. Rahman F, Siddiqui A, Singhal S, Ashraf H, Faraz A. Association of nerve conduction velocity with Total Body Fat Mass and Body Mass Index in type 2 diabetes mellitus physiology section. 2020;14(9):4–7. Available from: https://doi.org/10.7860/JCDR/2020/44524.1406
15. Bansal D, Gudala K, Muthyala H, Esam H prasad, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5(16):714-21. Available from: https://doi.org/10.1111/jdi.12223
16. Mao F, Zhu X, Liu S, Qiao X, Zheng H, Lu B, et al. Age as an independent risk factor for diabetic peripheral neuropathy in Chinese patients with type 2 diabetes. Aging Dis. 2019;10(3):592-600. Available from: https://doi.org/10.14336/AD.2018.0618
17. Sachedina S, Toth C. Association of comorbidities with increasing severity of peripheral neuropathy in diabetes mellitus. World J Diabetes. 2013;4(4):135–44. Available from: https://doi.org/10.4239/wjd.v4.i4.135
18. Sethi Y, Uniyal N, Vora V, Agarwal P, Murli H, Joshi A, et al. Hypertension the “Missed Modifiable Risk Factor” for diabetic neuropathy: a systematic review. Curr Probl Cardiol. 2023;48(4):101581. Available from: https://doi.org/10.1016/j.cpcardiol.2022.101581
19. Lord J, Reid K, Duclos C, Mai A, Odoi A. Investigation of predictors of severity of diabetes complications among hospitalized patients with diabetes in Florida, 2016–2019. BMC Public Health [Internet]. 2023;23(1):2424. Available from: https://doi.org/10.1186/s12889-023-17288-x
20. Siddiqui AH, Tauheed N, Ashraf H, Ahmad J. Association of sensory nerve action potential amplitude and velocity with type 2 diabetic peripheral neuropathy. Cureus. 2023;15(10):1–10. Available from: https://doi.org/10.7759/cureus.46501
21. Park JH, Park JH, Won JC. Associations of nerve conduction study variables with clinical symptom scores in patients with type 2 diabetes. Ann Clin Neurophysiol. 2019;21(1):36–43. Available from: https://doi.org/10.14253/acn.2019.21.1.36
22. Nurlaela S, Kurniawan SN, Husna M. Electroneuromyography examination of diabetic polyneuropathy patients.Malang Neurology Journal. 2019;5(1):1–4. Available from: https://mnj.ub.ac.id/index.php/mnj/article/view/305
23. Shrivastava R, Saluja A, Sharma B, Dave R, Shrivastava A. To evaluate peripheral neuropathy of ulnar sensory nerve through nerve conduction studies in Type 2 diabetic patients. Natl J Physiol Pharm Pharmacol. 2023;13(5):935–8. Available from: https://doi.org/10.5455/njppp.2023.13.09425202220092022
24. Nozawa K, Ikeda M, Kikuchi S. Association between HbA1c levels and diabetic peripheral neuropathy: a case-control study of patients with type 2 diabetes using claims data. Drugs Real World Outcomes [Internet]. 2022;9(3):403–14. Available from: https://doi.org/10.1007/s40801-022-00309-3
25. Elafros MA, Callaghan BC. Diabetic neuropathies. Continuum (Minneap Minn). 2023;29(5):1401–17. Available from: https://doi.org/10.1212/con.0000000000001291
26. Caprnda M, Mesarosova D, Ortega P, Krahulec B, Egom E, Rodrigo L, et al. Glycemic variability and vascular complications in patients with type 2 Diabetes Mellitus. Folia Med (Plovdiv). 2017;59(3):270-7. Available from: https://doi.org/10.1515/folmed-2017-0048
27. Su JB, Zhao LH, Zhang XL. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2018;17(1):47. Available from: https://doi.org/10.1186/s12933-018-0693-0
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2025 Dessy Natalia, Maria Belladonna Rahmawati, Maria Immaculata Widiastuti Samekto, Endang Kustiowati, Herlina Suryawati, Elta Diah Pasmanasari (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
